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It was late one night, in a busy ICU. The patient was a 68-year-old woman who had undergone orthotopic liver transplantation. She was admitted for urosepsis and needed 
hemodialysis in the context of multiorgan system 
failure. Now off dialysis, she had a serum creati-
nine level of 1.8 mg/dl. I wanted to estimate her 
glomerular filtration rate (GFR), which I knew 
was a hyperbolic function of plasma creatinine. 
She was a small lady with little muscle mass, so 
if her normal creatinine was 0.6, then her GFR 
should be about one-third normal. But her previ-
ous plasma creatinine measurements had been 
worse, and she was still making urine. What was 
her true renal function? Would she benefit from 
hemodialysis?
I’m just an intern. I thought that her creati-
nine of 1.8 didn’t sound that bad—definitely 
not the kind of level I’d seen in patients before 
dialysis. So I quickly calculated an estimated 
GFR (eGFR) with the world’s most popular 
prediction formula and got 30.0 ml/min. This 
seemed reasonable but perhaps a bit worse than 
I had expected. So I tried again with an older, 
weight-based formula. The result was similar at 
31.2 cc/min. What do these numbers mean? Or, 
more importantly for me that night, what was I 
supposed to say on morning rounds?
Earlier nephrologists measured the actual 
GFR when questions like this came along. In 
1926, Poul Rehberg laboriously collected his 
own urine hourly and plotted milligrams of 
creatinine excreted per minute against milli-
grams of creatinine per cubic centimeter of urine. 
The slope of his graph, 120–130 cc/min, was the 
first creatinine clearance measured in a human.1 
Today, wherever I turned, I found the eGFR. 
Why? Mostly, I suspect, because measuring GFR 
requires 24-hour urine collection. Collecting 
urine is annoying and often inaccurate, so we 
have been reduced to estimating renal function 
from the plasma creatinine alone.
There are many formulas that estimate clear-
ance based on plasma creatinine. The Cockcroft 
and Gault prediction formula yields an estimated 
GFR from creatinine, age, weight, and sex.2 It was 
the most highly used until 1999, when a six-var-
iable equation (creatinine, urinary urea, blood 
urea, race, age, and sex) came out of the Modifi-
cation of Diet in Renal Disease (MDRD) Study.3 
In 2000, the six-variable equation was revised to 
a simpler four-variable MDRD (4v-MDRD); this 
4v-MDRD is currently the most popular way of 
estimating GFR.4
How well does the 4v-MDRD work? I was 
surprised by how nephrologists answered this 
question. For every attending nephrologist who 
chided me for omitting to calculate eGFR, there 
was another who winced when eGFR was men-
tioned. Were my overnight calculations of eGFR 
useful or not? Interns want to make all the attend-
ings happy, and one never gets a second chance to 
make a first impression. Reading about this ques-
tion for my ICU patient taught me two truths: 
eGFR can never be perfect, and serious problems 
do exist in measuring serum creatinine.
Truth one: GFR is not immutable. The great 
Homer Smith knew that GFR changes depend-
ing on the time of day, salt and volume sta-
tus, blood pressure, diet, obesity, and illness. 
Although GFR is a logical proxy for nephron 
number, it is a functional measurement and 
subject to many regulatory influences. When 
nephrons are lost, the GFR of the remaining 
nephrons often increases to cause disparity 
between nephron number and function.
Truth two: Creatinine is hard to measure. 
Prediction formulas for eGFR depend on the 
accuracy of serum creatinine measurement. For 
example, in the original MDRD study, creatinine 
accounted for 80% of observed eGFR variability 
between patients. Alas, measuring creatinine is 
not easy. The concentration of normal serum cre-
atinine is so low, and the assay to measure it so 
troublesome, that its existence in the normal sera 
of mammals was doubted up until the 1920s. (In 
fact, Rehberg had ingested 5 grams of exogenous 
creatinine to make his measurement easier.) A 
simple acid–base assay called the Jaffe reaction 
has been the way of tabulating serum creatinine 
for over a century. Picric acid is added to cre-
atinine, causing emission in the orange–yellow 
spectrum. Unfortunately, other common blood 
constituents also emit in this spectrum: plasma 
proteins, glucose, fructose, pyruvate, acetoac-
etate, urate, and ascorbate. The Jaffe reaction is 
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inaccurate, consistently overestimating serum 
creatinine. It is also imprecise, erratically vary-
ing between labs on the basis of specific rea-
gents, analyzer machines, and techniques.5,6 A 
new, enzymatic assay reduces creatinine over-
estimation. This sounds good but is actually 
problematic, because the data in the 4v-MDRD 
were derived with the Jaffe reaction. When a 
more accurate (less overestimated) creatinine is 
plugged into the 4v-MDRD, it yields a deceptively 
high eGFR. For a while we lived in a topsy-turvy 
world where more accurate creatinines obtained 
in enzymatic reactions were being corrected to 
less accurate creatinines so that they could match 
the 4v-MDRD.7 This changed in the fall of 2005, 
when the MDRD group came out with a re-
expressed four-variable equation calibrated to 
gold-standard (mass spectrometry–determined) 
serum creatinine measurements.8 The National 
Kidney Disease Education Program is distribut-
ing these gold standards, and labs should start 
individually calibrating creatinine assays. At the 
moment, however, the situation is in flux and few 
labs calibrate. A foray to my hospital’s core lab 
taught me that we use a modified, uncalibrated 
Jaffe assay. So from a technical perspective, the 
original 4v-MDRD would be the best one to 
apply to my patient (rather than the re-expressed 
4v-MDRD from 2005). The precision of my core 
lab remains an open question.
There’s a final issue. How well can I apply 
the 4v-MDRD’s eGFR to my ICU patient? The 
MDRD cohort was 88% white, 94% free of dia-
betes, 100% free of obesity, and 51 years old 
on average. My patient is Spanish-speaking, 
diabetic, and 68 years old. Others have noted 
this problem and have responded by generat-
ing empirically derived versions of the MDRD 
for other populations: diabetics, transplant and 
cancer patients, Chinese, South Asians, Japa-
nese, Italians, Swedes, and older patients. I don’t 
find these ‘extra’ MDRDs particularly helpful. 
Which equation, for example, would I use in an 
elderly, diabetic, Latino-Chinese patient? The 
business of generating race- or nationality-
based prediction formulas is not well suited to 
polyglot New York, where I work.
Morning came slowly, and I was left with 
more quandaries than clarity. What does this 
patient’s eGFR mean? How can I blow away the 
fog and dispel the ghost that wavers before me? 
At last, rounds came, and my attending sug-
gested a way out of this haunted house: meas-
ure the creatinine clearance! Serum creatinine 
is fundamentally determined by the GFR and 
the muscle mass of the patient. The latter is not 
included in any of these formulations, in part 
because there is at present no accurate method 
to estimate it. The epiphany, my attending sug-
gested, is to recognize that eGFR is used by epi-
demiologists who must worry about what to do 
with thousands of patients. They can’t possibly 
examine or even see all these patients but want 
to generate conclusions that can apply broadly 
to populations. They want a test that is ‘close 
enough’ to the GFR but that doesn’t require 
24-hour urine collection. I have an advantage. 
I only want to know the renal function of the 
lady in front of me. So should I call the dialysis 
unit or not? We got the urine and found that in 
24 hours she excreted only 379 mg of creatinine 
in 715 ml of urine. Her creatinine clearance 
was 14.6 ml/min. The patient was put back on 
hemodialysis—and remains on it today.
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